Virologic Tools for HCV Drug Resistance Testing
Viruses, 2015 Recent advances in molecular biology have led to the development of new antiviral drugs that target specific steps of the Hepatitis C Virus (HCV) lifecycle. These drugs, collectively termed direct-acting antivirals (DAAs), include non-structural (NS) HCV
Slim Fourati, Jean-Michel Pawlotsky
doaj +1 more source
Association of Hepatitis C Virus Infection and Interleukin-28B Gene Polymorphism in Chinese Children [PDF]
, 1969 Rongrong Wu +3 more
openalex +1 more source
EASL recommendations on treatment of hepatitis C - Final update of the series.
Journal of Hepatology, 2020 J. Pawlotsky +8 more
semanticscholar +1 more source
Response Guided Interferon Therapy for Genotype 3 of Chronic Hepatitis C: Compliance and Outcome [PDF]
, 1969 Md Shahid Sarwar
openalex +1 more source
The epidemiology of hepatitis C in Switzerland: trends in notifications, 1988–2015 [PDF]
, 1970 Jean‐Luc Richard +3 more
openalex +1 more source
Hepatitis B, hepatitis C and HIV in Irish prisoners, part II: prevalence and risk in committal prisoners 1999. [PDF]
, 2000 The results of a census survey of 1205 Irish prisoners, published in August 1999, showed that the prevalence of infection with hepatitis B was 9%, the prevalence of infection with hepatitis C was 37%, and the prevalence of infection with HIV was 2%.
Allwright, Shane +5 more
core
The duck hepatitis B virus core protein contains a highly phosphorylated C terminus that is essential for replication but not for RNA packaging [PDF]
, 1989 H J Schlicht +2 more
openalex +1 more source
Binding of nuclear factor EF-C to a functional domain of the hepatitis B virus enhancer region. [PDF]
, 1989 Philomena Ostapchuk +2 more
openalex +1 more source
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Nature, 2009 D. Ge +12 more
semanticscholar +1 more source